Surgery Partners (SGRY) Receivables (2014 - 2026)

Surgery Partners has disclosed Receivables across 13 years of filings, most recently posting $603.4 million for Q1 2026.

• Receivables for Q1 2026 came in at $603.4 million, up 5.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $603.4 million (up 5.75% YoY), and the FY2025 annual result was $602.2 million, up 3.99% from the prior year.
• Receivables came in at $603.4 million for Q1 2026 at Surgery Partners, roughly flat from $602.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $603.4 million in Q1 2026 to a low of $412.0 million in Q2 2022.
• The 5-year median for Receivables is $496.4 million (2023), against an average of $507.3 million.
• Across the five-year window, Receivables climbed 17.31% in 2024 and rose 3.99% in 2025, its largest moves.
• Surgery Partners' Receivables stood at $456.3 million in 2022, then increased by 8.79% to $496.4 million in 2023, then increased by 16.66% to $579.1 million in 2024, then grew by 3.99% to $602.2 million in 2025, then increased by 0.2% to $603.4 million in 2026.
• The last three Receivables figures came in at $603.4 million (Q1 2026), $602.2 million (Q4 2025), and $579.3 million (Q3 2025), per Business Quant data.